FP/SAL

PreclinicalSmall molecule

GSK

FP/SAL is one of 22 small molecule programs targeting Asthma. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AsthmaActive, not recruiting

AsthmaPreclinical

Active, not recruiting

Competition

Competitive Landscape

1050 competitors in Asthma

#DrugCompanyPhaseTrials

Singulair

AstraZeneca

Preclinical

17 2

Cinqair

Teva

Preclinical

13 3

Dupixent

AAzienda U.S.L. 1 di Massa e Carrara

Preclinical

30 4

Qvar

Chiesi Farmaceutici S.p.A.

Preclinical

8 5

Spiriva

Boehringer Ingelheim

Preclinical

8 6

Atrovent

Boehringer Ingelheim

Preclinical

5 7

Arcoxia

Formoterol Fumarate

8 9

Aciphex

Akero Therapeutics

Preclinical

2 10

Tylenol

KKenvue Brands

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Asthma2 trials

Real-world Effectiveness of Combination Therapies in Primary Care Asthma Management

Completed·RResearch in Real-Life Ltd··NCT01908075·194,723 enrolled

Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma

Withdrawn· GSK logo

GSK·Phase 3·NCT03376932

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for FP/SAL. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — FP/SAL compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for FP/SAL. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — GSK company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: GSK

FP/SAL

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Asthma2 trials

References

Drug Info

Quick Facts

Related News